LCI 1318 (Terbutaline 2.5 mg)
Pill imprint LCI 1318 has been identified as Terbutaline sulfate 2.5 mg.
Terbutaline is used in the treatment of asthma, maintenance; premature labor; asthma, acute and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy. Terbutaline 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- LCI 1318
- 2.5 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Adrenergic bronchodilators
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Lannett Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
pregelatinized corn starch
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|68084-0256||Amerisource Health Services|
|10135-0579||Marlex Pharmaceuticals Inc|
More about terbutaline
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: adrenergic bronchodilators
- Terbutaline tablets
- Terbutaline (Advanced Reading)
- Terbutaline Subcutaneous (Advanced Reading)
Other brands: Brethine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.